scorecardresearch
Add as a preferred source on Google
Thursday, April 16, 2026
TopicGeneric drugs

Topic: Generic drugs

As semaglutide goes off patent, weight-loss gold rush begins. Pharma bets big, court case lingers

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic versions of the weight loss drugs in India.

How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the US

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, with chunk of their earnings hinging on exports to the country.

South Eastern Coalfields Limited opens fourth AMRIT Pharmacy in Bilaspur

Launched in 2015, the AMRIT pharmacies, a flagship initiative of the Ministry of Health and Family Welfare, offer a broad selection of generic and life-saving branded drugs, implants, and surgical supplies at heavily discounted prices.

Alliance of India’s 26 top drugmakers opposes generic drug substitution at Janaushadhi Kendras

Leading drugmakers express apprehension over CDSCO’s proposal to permit generic alternatives for key medications, emphasizing the risk of compromised drug quality.

24 mega-seller drugs set to lose patents in US, big opportunity for Indian drugmakers — govt report

Patent expiry would mean that drugmakers will be able to launch generic versions of the blockbuster drugs, which are typically priced up to 90 percent lower than their innovator drug.

Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...

Kerala doctors & researchers plan India’s 1st private drug quality assessment drive

Project follows outcry over NMC rule, now on hold, asking medical practitioners to prescribe generics or face penalty. Dr Cyriac Abby Philips or ‘@TheLiverDoc’ part of project.

Prescribe generics or face penalty? Govt asks NMC to modify controversial rule for doctors

Rule part of Registered Medical Practitioner (Professional Conduct) Regulations, 2023. Opponents include Indian Medical Association, but some see it as a move in the right direction.

Drugs regulator to probe ‘faulty’ optical lens by Swiss-American firm Alcon

The Central Drugs Standard Control Organisation has formed an inquiry committee following a complaint by ophthalmologist and ex-parliamentarian Dr Vikas Mahatme.

Amid FTA talks, top pharma firms urge govt not to amend patents law, warn of impact on cheap meds

India in trade talks with US, UK and EU. Pharma companies say 'provision for patent holders to extend life of patent on medicine beyond 20 yrs will delay entry of generic medicine'.

On Camera

Avalanche, enemy fire, and a strategy—how Indian Army took control of Siachen

The force for the operation was to be maintained by air through para drops by fixed wing aircrafts while the helicopter effort was primarily earmarked for tasks such as reconnaissance.

Russia raking in a windfall from Hormuz blockade. Export revenues doubled to $19 bn in March, says IEA

Despite damage to key Russian oil infrastructure by Ukrainian drone strikes in March, International Energy Agency data shows Russia’s earnings in March were highest for any month since January 2024.

Why Siliguri Corridor is strategically important for India & how it is being secured | Cut The Clutter

This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.

The world’s in a flux. India must reform, consolidate & build a strong economy

We now live in a world order that will keep shifting. India must use this window. This also means we remain disciplined enough not to be knee-jerked into reacting to what Pakistan sees as its moment in the sun.